These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 9264359)
1. Prostate carcinoma and long term survival. Adolfsson J; Rutqvist LE; Steineck G Cancer; 1997 Aug; 80(4):748-52. PubMed ID: 9264359 [TBL] [Abstract][Full Text] [Related]
2. Survival in prostate carcinoma--outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: results from three countries in the population-based National Prostate Cancer Registry of Sweden. Aus G; Robinson D; Rosell J; Sandblom G; Varenhorst E; Cancer; 2005 Mar; 103(5):943-51. PubMed ID: 15651057 [TBL] [Abstract][Full Text] [Related]
3. Prostate cancer mortality in patients surviving more than 10 years after diagnosis. Hugosson J; Aus G; Bergdahl C; Bergdahl S J Urol; 1995 Dec; 154(6):2115-7. PubMed ID: 7500471 [TBL] [Abstract][Full Text] [Related]
4. Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia: a population-based cohort study in Sweden. Chokkalingam AP; Nyrén O; Johansson JE; Gridley G; McLaughlin JK; Adami HO; Hsing AW Cancer; 2003 Oct; 98(8):1727-34. PubMed ID: 14534890 [TBL] [Abstract][Full Text] [Related]
5. Overall survival in the intervention arm of a randomized controlled screening trial for prostate cancer compared with a clinically diagnosed cohort. Vis AN; Roemeling S; Reedijk AM; Otto SJ; Schröder FH Eur Urol; 2008 Jan; 53(1):91-8. PubMed ID: 17583416 [TBL] [Abstract][Full Text] [Related]
6. Age specific risks of familial prostate carcinoma: a basis for screening recommendations in high risk populations. Grönberg H; Wiklund F; Damber JE Cancer; 1999 Aug; 86(3):477-83. PubMed ID: 10430256 [TBL] [Abstract][Full Text] [Related]
7. Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis. Brenner H; Arndt V J Clin Oncol; 2005 Jan; 23(3):441-7. PubMed ID: 15572727 [TBL] [Abstract][Full Text] [Related]
8. Advanced age at diagnosis is an independent predictor of time to death from prostate carcinoma for patients undergoing external beam radiation therapy for clinically localized prostate carcinoma. D'Amico AV; Cote K; Loffredo M; Renshaw AA; Chen MH Cancer; 2003 Jan; 97(1):56-62. PubMed ID: 12491505 [TBL] [Abstract][Full Text] [Related]
9. Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy. Krupski TL; Smith MR; Lee WC; Pashos CL; Brandman J; Wang Q; Botteman M; Litwin MS Cancer; 2004 Aug; 101(3):541-9. PubMed ID: 15274067 [TBL] [Abstract][Full Text] [Related]
10. Progression of mean age and mean expected mortality rate by duration of follow up in cohorts with a wide range of age. Singer RB J Insur Med; 2006; 38(3):181-91. PubMed ID: 17076138 [TBL] [Abstract][Full Text] [Related]
11. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening. Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715 [TBL] [Abstract][Full Text] [Related]
12. Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up. Ragde H; Korb LJ; Elgamal AA; Grado GL; Nadir BS Cancer; 2000 Jul; 89(1):135-41. PubMed ID: 10897010 [TBL] [Abstract][Full Text] [Related]
13. Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy). Tewari A; Raman JD; Chang P; Rao S; Divine G; Menon M Urology; 2006 Dec; 68(6):1268-74. PubMed ID: 17169648 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
16. Mortality of patients with clinically localized prostate cancer treated with observation for 10 years or longer: a population based registry study. Brasso K; Friis S; Juel K; Jørgensen T; Iversen P J Urol; 1999 Feb; 161(2):524-8. PubMed ID: 9915440 [TBL] [Abstract][Full Text] [Related]
17. Conditional relative survival of cancer patients and conditional probability of death: a French National Database analysis. Bouvier AM; Remontet L; Hédelin G; Launoy G; Jooste V; Grosclaude P; Belot A; Lacour B; Estève J; Bossard N; Faivre J; Cancer; 2009 Oct; 115(19):4616-24. PubMed ID: 19569252 [TBL] [Abstract][Full Text] [Related]
18. Improved survival of patients with prostate cancer in northern Denmark, 1985-2004. Lund L; Jacobsen J; Borre M; Larsen EH; Graversen PH; Sørensen HT; Nørgaard M; Scand J Urol Nephrol; 2007; 41(4):308-13. PubMed ID: 17763222 [TBL] [Abstract][Full Text] [Related]
19. Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men. Gong Z; Agalliu I; Lin DW; Stanford JL; Kristal AR Cancer Causes Control; 2008 Feb; 19(1):25-31. PubMed ID: 17906959 [TBL] [Abstract][Full Text] [Related]
20. Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival. Cheville JC; Tindall D; Boelter C; Jenkins R; Lohse CM; Pankratz VS; Sebo TJ; Davis B; Blute ML Cancer; 2002 Sep; 95(5):1028-36. PubMed ID: 12209687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]